Analysts at Morgan Stanley estimate consumption of fizzy soft drinks, baked goods and salty snacks in the US could fall by up to 3% by 2035.
They estimate that 24 million people, or 7% of the US population, will be taking the new GLP-1 drugs by 2035. A survey carried out of 300 patients taking the shots showed they ate less and cut back the most on foods high in sugar and fat. About 90% of those using the drugs said their snacking declined and 77% said they visited fast-casual restaurants less often.
Obviously this hides poorly for many companies in these sectors. McDonald’s has tried healthier menu items and they have largely failed. Weight loss drugs are getting cheaper and will be used widely.
The fast food and junk food sectors are ones I am going to stay away from.
Leave a Reply